EGFL6 and neoplasm: Consistent with an immunosuppressive TME, ID8-Egfl6+ tumor ascites had fewer CD8+ T cells than the control ascites (Figure 2H, top panel), and there was reduction in the percentage of CD8+ T cells producing IFN-γ (Figure 2H, bottom panel).